+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antifungal Drug"

From
Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • May 2025
  • 116 Pages
  • Global
From
Sepsis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Sepsis Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 291 Pages
  • Global
From
Invasive Fungal Infections Market Report 2025 - Product Thumbnail Image

Invasive Fungal Infections Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Candidiasis Therapeutics Market Report 2025 - Product Thumbnail Image

Candidiasis Therapeutics Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
From
From
Vulvovaginal Candidiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Vulvovaginal Candidiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Candidiasis - Pipeline Insight, 2025 - Product Thumbnail Image

Candidiasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Candidemia - Pipeline Insight, 2025 - Product Thumbnail Image

Candidemia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Invasive Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Invasive Aspergillosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Aspergillosis - Pipeline Insight, 2025 - Product Thumbnail Image

Aspergillosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Chronic Pulmonary Infections- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Pulmonary Infections- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Otomycosis - Pipeline Insight, 2025 - Product Thumbnail Image

Otomycosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Meningitis - Pipeline Insight, 2025 - Product Thumbnail Image

Meningitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Cryptococcosis - Pipeline Insight, 2025 - Product Thumbnail Image

Cryptococcosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Onychomycosis - Pipeline Insight, 2025 - Product Thumbnail Image

Onychomycosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chagas Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Chagas Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Loading Indicator

The Antifungal Drug market is a subset of the larger Infectious Diseases Drugs market. Antifungal drugs are used to treat fungal infections, which can range from mild to life-threatening. These drugs work by either killing the fungus or preventing its growth. Common antifungal drugs include azoles, polyenes, and echinocandins. Azoles are the most commonly prescribed antifungal drugs, and are used to treat a wide range of fungal infections. Polyenes are used to treat more serious fungal infections, while echinocandins are used to treat severe fungal infections. The Antifungal Drug market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Other companies in the market include Bayer, Sanofi, Allergan, and Johnson & Johnson. Show Less Read more